Single Cell Technology, Inc.

  • 公司英文名稱:Single Cell Technology, Inc.
  • 公司網址:https://www.singlecelltechnology.com
  • 發展階段:海外
  • 公司地區: 6280 San Ignacio Ave. Suite E, San Jose, CA 9511

產業領域

C06再生醫療(細胞治療、基因治療、組織工程等)

公司簡介

Single Cell Technology (SCT) was established in 2008. We named our antibody discovery technology after the Greek word atheneum, meaning an institute for scientific learning. AbTheneum™ technology was independently developed by merging 8 different fields. SCT has been helping global pharmaceutical companies find sought-after antibodies against unusual or difficult drug targets since 2016.

應用市場

SCT’s AbTheneum™ platform combines micro-fabrication, next generation DNA sequencing (NGS), molecular biology, mechanical engineering, and bioinformatics together with patents and trade secrets. Output from AbTheneum™ is displayed as a compendium of Big Data in what is called the Antibody Atlas™. Each study focused on a different target protein has its own proprietary Antibody Atlas™. AbTheneum™ has been used to isolate hundreds to thousands of antibodies against various immune-oncology drug targets as well as the spike protein of SARS-CoV-2 virus. Recent validation experiments showed SCT’s anti-spike antibodies are on par with or better than those developed by Regeneron or Eli Lilly in terms of neutralization potency.

相關文章